Viewing nowPregablin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201109154 · Approved 2011.10.25 · Insurance code 650302840
Treatment of neuropathic pain, treatment of fibromyalgia, adjunctive treatment of partial-onset seizures
This medication is used to treat peripheral and central neuropathic pain in adults. It is also used as an adjunct for patients with epilepsy, regardless of the presence of secondary generalized symptoms for partial seizures. Additionally, it is effective in the treatment of fibromyalgia. In summary, it is used to improve various neurological symptoms such as neuropathic pain, epileptic seizures, and fibromyalgia.
This medication is administered orally as pregabalin, in 2 divided doses per day, with or without food. Since this medication is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See “5. Patients with Renal Impairment”) 1. Neuropathic Pain 1) Peripheral Neuropathic Pain Adults: This medication may be administered at an initial dose of 150 mg/day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals up to a maximum of 600 mg/day. 2) Central Neuropathic Pain Adults: This medication may be administered at an initial dose of 150 mg/day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See “4. Discontinuation of Treatment”) 2. Epilepsy Adults: This medication may be administered at an initial dose of 150 mg/day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may then be increased at 7-day intervals up to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medication for fibromyalgia is 300 mg-450 mg/day. The initial dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies were also conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, if treatment with this medication is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this medication is primarily excreted by the kidneys as unchanged drug. Since the clearance of this medication is directly affected by creatinine clearance, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *For women, multiply the result obtained using the above formula by 0.85. This medication is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin Dosage Based on Renal Function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalina Administration schedule Initial dose (mg/day) Maximum dose (mg/day) ≥60: Initial dose 150 mg/day, maximum dose 600 mg/day, BID or TID ≥30-<60: Initial dose 75 mg/day, maximum dose 300 mg/day, BID or TID ≥15-<30: Initial dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID <15: Initial dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: Initial dose 25 mg, maximum dose 100 mg, single dose b TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified under the administration schedule. b: The supplemental dose refers to a dose administered as a single additional dose. 6. Patients with Hepatic Impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older Adults (65 years of age and older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Administration is not recommended because data on safety and efficacy are insufficient. Adolescent patients aged 12-17 years: Administration is not recommended because data on safety and efficacy are insufficient.
This medication may increase the risk of suicidal thoughts or behavior, so you should immediately inform your healthcare provider if you experience depression or mood changes while taking it. Patients with hypersensitivity to this drug or certain genetic metabolic disorders should not take it. Diabetic patients should be cautious as dosage adjustments of blood glucose control medications may be needed due to weight gain. If symptoms of angioedema appear, the drug should be discontinued immediately. Elderly patients are at higher risk of injury due to dizziness or drowsiness, so special care is needed initially. Transient visual blurriness or changes may occur, and if these symptoms appear, consultation with healthcare personnel should be obtained. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so dosage should be reduced gradually as per physician's instructions. Patients with a history of substance abuse should be carefully monitored due to the high potential for misuse of this medication. Patients with reduced renal function may require dosage adjustments. Patients with heart disease should exercise caution when taking this medication, particularly those with congestive heart failure. Caution is needed when taking this medication with opioid analgesics as the risk of central nervous system depression may increase. This medication may cause dizziness and drowsiness, so it is advised to avoid driving or operating hazardous machinery until you know how it affects you. In early pregnancy, there may be a risk of fetal malformation, so pregnant women should not take this medication, and women of childbearing age should use effective contraception. During breastfeeding, this medication may be transmitted through breast milk, so you may need to consider stopping breastfeeding or discontinuing the medication. In the case of overdose, symptoms may include drowsiness, confusion, seizures, and treatment such as hemodialysis may be necessary. Children and the elderly should be particularly cautious when taking this medication, and it should be stored out of the reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best to store it at room temperature between 15 to 30 degrees Celsius. To maintain the effectiveness of the medication, it is essential to avoid direct sunlight and not to store it in excessively hot or cold places.
White hard capsule containing white powder
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.